+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Argon laser peripheral iridoplasty versus systemic intraocular pressure-lowering medications as immediate management for acute phacomorphic angle closure

Argon laser peripheral iridoplasty versus systemic intraocular pressure-lowering medications as immediate management for acute phacomorphic angle closure

Clinical Ophthalmology 7: 63-69

The purpose of this study was to compare the efficacy and safety of argon laser peripheral iridoplasty (ALPI) and systemic intraocular pressure (IOP)-lowering medications in the immediate management of acute phacomorphic angle closure. Consecutive cases of acute phacomorphic angle closure were randomized to receive ALPI and an intravenous or oral carbonic anhydrase inhibitor as initial treatment. Intravenous mannitol was administered for presenting IOP > 60 mmHg or IOP > 40 mmHg 2 hours posttreatment in both arms. Of 10 consecutive cases, six received medical therapy and four received ALPI. Fifty percent in the medical group and none in the ALPI group required intravenous mannitol. The ALPI group took less time to achieve IOP < 25 mmHg (18.8 ± 7.5 minutes versus 115.0 ± 97.0 minutes, P = 0.001, F test); had a greater IOP reduction within 30 minutes (69.8% ± 7.7% versus 40.9 ± 23.9%, P = 0.03, t-test); and had a consistently smaller post-attack cup to disc ratio (0.50 ± 0.02 versus 0.60 ± 0.20, P = 0.002, F test). ALPI offers greater safety, consistency, and efficacy than systemic IOP-lowering medications as initial treatment for phacomorphic angle closure.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 051633547

Download citation: RISBibTeXText

PMID: 23326185

DOI: 10.2147/opth.s39503

Related references

Immediate argon laser peripheral iridoplasty (ALPI) as initial treatment for acute phacomorphic angle-closure (phacomorphic glaucoma) before cataract extraction: a preliminary study. Eye 19(7): 778-783, 2004

To compare argon laser peripheral iridoplasty (ALPI) against systemic medications in treatment of acute primary angle-closure: mid-term results. Eye 20(3): 309-314, 2005

Argon laser peripheral iridoplasty versus conventional systemic medical therapy in treatment of acute primary angle-closure glaucoma: A prospective, randomized, controlled trial. Ophthalmology 109(9): 1591-1596, 2002

Argon laser peripheral iridoplasty and anterior segment optical coherence tomography in the management of acute angle closure in the 21st century. Archivos de la Sociedad Espanola de Oftalmologia 93(6): E40, 2018

Argon laser peripheral iridoplasty in the management of phacomorphic glaucoma. Ophthalmic Surgery Lasers and Imaging 36(4): 286-291, 2005

Laser therapy for angle closure glaucoma 2 relationship between effect of argon laser iridotomy on intraocular pressure and ratio of peripheral anterior synechiae in primary acute angle closure glaucoma. Folia Ophthalmologica Japonica: 206-210, 1985

Argon laser peripheral iridoplasty for topiramate-induced bilateral acute angle closure. Journal of Glaucoma 18(4): 269-271, 2009

Argon-laser iridoplasty in the management of uveitis-induced acute angle-closure glaucoma. European Journal of Ophthalmology 19(2): 304-306, 2009

Immediate argon laser peripheral iridoplasty as treatment for acute attack of primary angle-closure glaucoma: a preliminary study. Ophthalmology 105(12): 2231-2236, 1998

Long-term intraocular pressure fluctuation of primary angle closure disease following laser peripheral iridotomy/iridoplasty. Chinese Medical Journal 124(19): 3066-3069, 2011

Acute angle-closure glaucoma in a patient with acquired immunodeficiency syndrome successfully treated with argon laser peripheral iridoplasty. Ophthalmic Surgery 21(7): 501-502, 1990

Limited argon laser peripheral iridoplasty as immediate treatment for an acute attack of primary angle closure glaucoma: a preliminary study. Eye 13: 26-30, 1999

Comparison of corneal transmissibility of 810nm diode laser with 488nm argon laser Diode laser peripheral iridoplasty/iridotomy in acute angle closure glaucoma. IOVS 39(4): S472, 1998

Recurrent acute angle-closure attack due to plateau iris syndrome after cataract extraction with or without argon laser peripheral iridoplasty: a case report. Bmc Ophthalmology 16: 64, 2016

Argon Laser Peripheral Iridoplasty for Primary Angle-Closure Glaucoma: A Randomized Controlled Trial. Ophthalmology 123(3): 514-521, 2016